Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center

The following new funding awards to JCCC members were announced in May 2013:

.Principal Investigator: Braun, Jonathan

Sponsor Name: Oklahoma Medical Research Foundation

Award Title: Role of Mucin-Type O-Glycans in Intestinal Inflammation

Principal Investigator: Bastani, Roshan

Sponsor Name: NIH/National Cancer Institute

Award Title: Increasing HPV Vaccine Uptake in a Low Income Ethnic Minority Population

Principal Investigator: Brooks, David

Sponsor Name: NIH/National Institute of Allergy and Infectious Diseases

Award Title: Mechanisms of Viral Persistence

Principal Investigator: Cheng, Genhong

Sponsor Name: NIH/National Institute of Allergy and Infectious Diseases

Award Title: Mechanisms of Biodefense By Toll-Like Receptors

Principal Investigator: Cole, Steven

Sponsor Name: University of Texas, Houston (Incl M.D, Anderson Cancer Center)

Award Title: Ovarian Cancer: Mechanisms of Neuroendocrine Regulation

Principal Investigator: Chiou, Pei-Yu

Sponsor Name: NIH Natl Institute of Biomedical Imaging & Bioengineering

Award Title: Microfluidics-Integrated Photothermal Nanoblade for High Throughput Large Cargo Delivery

Principal Investigator: Detels, Roger

Sponsor Name: Northern California Institute for Research and Education

Award Title: Aging Kidney in HIV-Infection: Biomarkers for Early Detection of Injury

Principal Investigator: Dorshkind, Kenneth

Sponsor Name: NIH/National Institute on Aging

Award Title: Effects of P16ink4a and Arf on T Lineage Aging

Principal Investigator: Eradat, Herbert

Sponsor Name: Eli Lilly and Company

Award Title: Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin

Principal Investigator: Gasson, Judith

Sponsor Name: NIH/National Cancer Institute

Award Title: Cancer Center Core Support Grant

Principal Investigator: Gimzewski, James

Sponsor Name: National Institute for Materials Science (Japan)

Award Title: Advanced Neural Network System and Nano-X-Ray System

Principal Investigator: Graeber, Thomas

Sponsor Name: Concern Foundation 

Award Title: Signaling Changes That Confer Resistance to Braf-Targeted Melanoma Therapy

Principal Investigator: Goldman, Jonathan

Sponsor Name: Eli Lilly and Company

Award Title: Phase 1 Safety Study of Ly2787106 in Patients with Cancer and Anemia

Principal Investigator: Hevener, Andrea

Sponsor Name: NIH/National Institute of Diabetes, Digestive and Kidney Disease

Award Title: Impact of Heat Shock Protein Expression on Inflammation and Insulin Action

Principal Investigator: Kahn, Katherine

Sponsor Name: Rand Corporation

Award Title: Cancer Care Outcome Research and Surveillance Consortium (Cancors)

Principal Investigator: Konecny, Gottfried

Sponsor Name: Pfizer Inc. (Incl Warner-Lamber and Parke-Davis)

Award Title: Open Label Phase II Study of the Efficacy and Safety of Pd0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6

Principal Investigator: McBride, William

Sponsor Name: NIH/National Institute of Allergy and Infectious Diseases

Award Title: UCLA Center for Biological Radiation Mitigators

Principal Investigator: Martinez, Otoniel 

Sponsor Name: City of Hope (Beckman Research Institute)

Award Title: Molecular Epidemiology of Non-Hodgkin Lymphoma Prognosis and Prevention

Principal Investigator: McCarthy, William

Sponsor Name: NIH/National Heart, Lung, and Blood Institute

Award Title: Family and Neighborhood Interventions to Reduce Heart Disease Risk in East L.A.

Principal Investigator: Nel, Andre

Sponsor Name: NIH/National Institute of Environmental Health Sciences

Award Title: Center for Nanobiology and Predictive Toxicology

Principal Investigator: Pajonk, Frank

Sponsor Name: NIH/National Cancer Institute

Award Title: Erythropoietin and Breast Cancer Stem Cells

Principal Investigator: Rao, Jian

Sponsor Name: Clavis Pharma Asa (Norway)

Award Title: Hent1 Study for AML and Pancreatic Cancers

Principal Investigator: Ritz, Beate 

Sponsor Name: NIH/National Institute of Environmental Health Sciences

Award Title: Parkinson's Diseases Susceptibility Genes and Pesticides

Principal Investigator: Rosen, Lee

Sponsor Name: Genentech, Inc.

Award Title: Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of Gdc-0973/Xl518 Administered Orally Daily to Subjects with Solid Tumors

Principal Investigator: Ribas, Antoni

Sponsor Name: Hoffmann-La Roche Inc. (incl Roche Molecular Systems)

Award Title: Open-Label, Multi-Center Phase II Study of Continuous Oral Dosing of Ro5185426 in Previously Treated Patients with Metastatic Melanoma 

Principal Investigator: Slamon, Dennis 

Sponsor Name: Cal Institute for Regenerative Medicine (CIRM)

Award Title: Therapeutic Opportunities to Target Tumor Initiating Cells in Solid Tumors

Principal Investigator: Stanton, Annette

Sponsor Name: NIH/National Cancer Institute

Award Title: Emotion Regulation and Depression in Breast Cancer Survivorship

Principal Investigator: Saigal, Christopher

Sponsor Name: NIH/National Cancer Institute

Award Title: Conjoint Analysis: Overcoming Obstacles to Routine Assessment in Men with Prostate Cancer

Principal Investigator: Tamanoi, Fuyuhiko

Sponsor Name: NIH/National Cancer Institute

Award Title: Nanovalve Platform: Targeted, Controlled Release of Anticancer Drugs 

Principal Investigator: Teitell, Michael

Sponsor Name: NIH/National Cancer Institute

Award Title: Fourth Outcome: DNA Damage and the Differentiation of B Cells

Principal Investigator: Weiss, Shimon

Sponsor Name: NIH/National Institute of General Medical Sciences

Award Title: Single-Photon Counting Apd Arrays for High-Through-Put Single-Molecule Assays

Principal Investigator: Wainberg, Zev

Sponsor Name: INC Research

Award Title: Phase 1, Open Label, Dose Escalation Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of the PI3/MTOR Inhibitor PF-04691502 in Adult

Principal Investigator: Wainberg, Zev

Sponsor Name: Imclone Systems, Inc.

Award Title: Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel with or without Ramucirumab (IMC-1121B) Drug Product

Principal Investigator: Wang, Cun Yu

Sponsor Name: NIH/National Institute of Dental and Craniofacial Research

Award Title: PS-341-Induced Apoptosis in Squamous Cell Carcinoma

Principal Investigator: Weiss, Paul

Sponsor Name: U.S. Department of Energy (Chicago Operations Office)

Award Title: Beneath and Between: Structural, Functional, and Spectroscopic Measurements of Buried Interfaces and Interactions

Principal Investigator: Xing, Yi

Sponsor Name: University of Iowa

Award Title: Genomic Signatures of Gene Expression and Alternative Splicing in Preterm Birth

Principal Investigator: Xing, Yi

Sponsor Name: NIH/National Institute of Neurological Disorders & Stroke

Award Title: Transcriptome in Huntington's Disease and Huntington's Disease-Like 2

Principal Investigator: Zink, Jeffrey

Sponsor Name: NIH/National Cancer Institute

Award Title: Nanovalve Platform: Targeted, Controlled Release of Anticancer Drugs

Principal Investigator: Zeltzer, Lonnie

Sponsor Name: Baylor College of Medicine

Award Title: Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors (Core)

Principal Investigator: Zack, Jerome

Sponsor Name: NIH/National Institute of Allergy and Infectious Diseases

Award Title: UCLA Center for AIDS Research (CFAR):Examining the Impact of Sexual Violence and Health-Related Immune Functioning on HIV Transmission and Progression

Principal Investigator: Zhang, Zuofeng

Sponsor Name: University of Texas, Houston (Incl MD, Anderson Cancer Center)

Award Title: Genomewide Study of Lung Cancer in Never Smokers

Principal Investigator: Zhang, Zuofeng

Sponsor Name: University of Texas, Houston (Incl MD, Anderson Cancer Center)

Award Title: Genome Wide Association Study of Head and Neck Cancer

Principal Investigator: Zeng, Gang

Sponsor Name: NIH/National Cancer Institute

Award Title: A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment

 

Last updated: 9/11/2013 11:51:38 AM